Vertex Pharmaceuticals Inc. buy Piper Sandler
Start price
27.01.25
/
50%
€425.65
Target price
27.01.26
€507.36
Performance (%)
-6.80%
End price
28.01.26
€396.70
Summary
This prediction ended on 28.01.26 with a price of €396.70. With a performance of -6.80%, the BUY prediction by Piper_Sandler finished with a loss. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 2.116% | 2.116% | -5.654% |
| iShares Core DAX® | -3.520% | -4.987% | 1.926% |
| iShares Nasdaq 100 | 0.261% | 1.102% | 15.434% |
| iShares Nikkei 225® | -4.953% | -3.352% | 29.010% |
| iShares S&P 500 | -0.823% | -0.042% | 10.814% |
Comments by Piper_Sandler for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at Piper Sandler from $535.00 to $533.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Piper_Sandler for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€451.85
02.08.24
02.08.24
€489.95
02.08.25
02.08.25
-11.64%
03.08.25
03.08.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€371.70
07.05.24
07.05.24
€423.03
07.05.25
07.05.25
2.92%
08.05.25
08.05.25